Beihai Gofar Chuanshan Biological Co., Ltd. (SHA:600538)

SHA:600538 Revenue

Beihai Gofar Chuanshan Biological had revenue of 82.65M CNY in the quarter ending March 31, 2026, with 5.13% growth. This brings the company's revenue in the last twelve months to 332.27M, up 0.23% year-over-year. In the year 2025, Beihai Gofar Chuanshan Biological had annual revenue of 328.24M, down -3.59%.

• Revenue (ttm): 332.27M
• Revenue Growth: +0.23%
• P/S Ratio: 10.98
• Revenue / Employee: 758.61K
• Employees: 438
• Market Cap: 3.65B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	328.24M	-12.23M	-3.59%
Dec 31, 2024	340.47M	-28.69M	-7.77%
Dec 31, 2023	369.15M	-90.53M	-19.69%
Dec 31, 2022	459.68M	34.97M	8.23%
Dec 31, 2021	424.72M	157.02M	58.65%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 20, 2026

Data Sources Report a data error